The Hemodynamic Effects of SGLT2i in Acute Decompensated Heart Failure
Status:
Not yet recruiting
Trial end date:
2023-05-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to observe hemodynamic effects of initiating sodium-glucose
co-transporter 2 inhibitors (SGLT2i) in patients admitted to the intensive care unit (ICU)
with acute decompensated heart failure.